Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

173.46
BATS BZX Real-Time Price
As of 2:05pm ET
 +0.85 / +0.49%
Today’s Change
133.64
Today|||52-Week Range
176.85
+18.64%
Year-to-Date
Better Cloud Growth Stock: Twilio Inc. vs. Veeva Systems
10:36am / MotleyFool.com - Paid Partner Content
Top Research Reports for Amgen, Bank of America, and Proctor & Gamble
Feb 21 / Zacks.com - Paid Partner Content
Who Could Buy Bristol-Myers Squibb?
Feb 22 / MotleyFool.com - Paid Partner Content
Study Reveals PCSK9 Drugs Can Save Heart Disease Patients
Feb 21 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Amgen, Procter & Gamble, Bank of America, Netflix ...
Feb 22 / Zacks.com - Paid Partner Content
The Four Key Themes From Q4 Conference Calls
Feb 17 / Investing Channel - Paid Partner Content
Heart-Thumping, Game-Changing Ways We're Treating Cardiovascular Disease
Feb 22 / MotleyFool.com - Paid Partner Content
Mylan's Proposed Biosimailar for Cancer Under Review in U.S.
Feb 17 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Alexion Reports 4Q Results, Celgene MS Drug Looks Promising
Feb 22 / Zacks.com - Paid Partner Content
Valeant's (VRX) Plaque Psoriasis Drug Approved in the U.S.
Feb 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close172.61
Today’s open173.05
Day’s range171.91 - 173.55
Volume69,562
Average volume (3 months)3,994,980
Market cap$127.1B
Dividend yield2.65%
Data as of 2:05pm ET, 02/23/2017

Growth & Valuation

Earnings growth (last year)+13.02%
Earnings growth (this year)+6.49%
Earnings growth (next 5 years)+7.78%
Revenue growth (last year)+7.76%
P/E ratio17.3
Price/Sales4.80
Price/Book4.26

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.44+0.64%
BIIBBiogen-3.57-1.24%
ILMNIllumina Inc-1.20-0.74%
BIVVBioverativ Inc+2.59+5.42%
Data as of 2:05pm ET, 02/23/2017

Financials

Next reporting dateApril 25, 2017
EPS forecast (this quarter)$2.99
Annual revenue (last year)$23.0B
Annual profit (last year)$7.7B
Net profit margin33.59%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts


Search for Jobs